Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
AGMB compared with OCS: revenue, margins and what each company keeps, and the suppliers and customers both name
AGMB
Agomab Therapeutics NV
Change
Mkt cap
Revenue
Revenue
OCS
Oculis Holding AG
Change
Mkt cap
Revenue
Revenue
vs
Compare
AGMB
Agomab Therapeutics NV
vs
OCS
Oculis Holding AG
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Earnings history
Desk
News
Calendar
Saved
Search
Earnings history
last 4 reports each · paired by recency
Method
›
No earnings history for AGMB. No earnings history for OCS.
AGMB
Agomab Therapeutics NV
Change
6.80
▲
+1.19%
· post 6.80
· delayed
Mkt cap
$229.6M
OCS
Oculis Holding AG
Change
7.63
▼
−1.02%
· post 7.63
· delayed
After hours
Nov 3 '26
delayed
Mkt cap
$463.3M
vs
Compare
After hours
Nov 3 '26
delayed
AGMB
Agomab Therapeutics NV
vs
OCS
Oculis Holding AG
6.80
▲
+1.19%
post 6.80
delayed
Price
7.63
▼
−1.02%
post 7.63
delayed
$229.6M
Mkt cap
$463.3M
Change
Change
AGMB
6.80
▲
+1.19%
vs
OCS
7.63
▼
−1.02%
After hours
Nov 3 '26
delayed